# A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

> **NCT00266578** · PHASE3 · COMPLETED · sponsor: **Marc Rothenberg** · enrollment: 30 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Fluticasone Propionate

## Key facts

- **NCT ID:** NCT00266578
- **Lead sponsor:** Marc Rothenberg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2006-11
- **Final completion:** 2012-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266578, "A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00266578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*